Companies Companies Boston Scientific Boston Scientific in Fortune Rankings Boston Scientific Corporation is a medical technology company that develops minimally invasive therapies and devices to address heart failure and rhythm disorders, gastrointestinal problems, and chronic pain. The company is known for its Watchman implant, designed to reduce the risk of stroke and heart attack in people with atrial fibrillation and to reduce their reliance on blood thinners.
Tang Yanjun—China News Service/VCG/Getty Images
Company Information World's Most Admired Companies America's Most Innovative Companies Key Financials (last Fiscal Year) Profit Ratios Earnings Per Share (last Fiscal Year) Total Return
Company Information Company Information World's Most Admired Companies America's Most Innovative Companies Key Financials (last Fiscal Year) Profit Ratios Earnings Per Share (last Fiscal Year) Total Return Updated: 6/3/26 Country/Territory: U.S. Headquarters: Marlborough, Mass. Industry: Medical Products and Equipment CEO: Michael F. Mahoney Website: https://www.bostonscientific.com Ticker: BSX Company type: Public Revenues ($M): $20,074 Profits ($M): $2,898 Market value ($M): $93,258 Number of employees: 59,000 Market value as of March 31, 2026.
Sector: Precision Industry: Medical Products and Equipment Current All-Star Rank: - Previous All-Star Rank: - Industry Rank: 2 Previous Industry Rank: 3 Overall Score: 7 Innovation: 1 People Management: 2 Use of Corporate Assets: 1 Social Responsibility: 5 Quality of Management: 2 Financial Soundness: 4 Long-Term Investment Value: 2 Quality of Products/Services: 3 Global Competitiveness: 5 Sector: Health Care Strongest Dimension: Product innovation Years on list: 3 Previous rank: 20 State: Massachusetts $ millions % change Revenues ($M): $20,074 19.9% Profits ($M): $2,898 56.4% Assets ($M): $43,673 - Total Stockholder Equity ($M): $24,233 - Profit as % of Revenues: 14.4% Profits as % of Assets: 6.6% Profits as % of Stockholder Equity: 12% Earnings Per Share ($): 1.90 EPS % Change (from prior fiscal year): 55.2% EPS % Change (5 year annual rate): - EPS % Change (10 year annual rate): - Total Return to Investors (last year): 6.8% Total Return to Investors (5 year, annualized): 21.5% Total Return to Investors (10 year, annualized): 17.9%
Boston Scientific stock chart Latest news on Boston Scientific Boston Scientific in Fortune Rankings Fortune 500 America's Most Innovative Companies World's Most Admired Companies Fortune Sector Leaders: Health Care
Fortune 500 Fortune 500 America's Most Innovative Companies World's Most Admired Companies Fortune Sector Leaders: Health Care 